A recent study evaluating second primary cancer risks in over 25,000 BRCA1 pathogenic variant carriers diagnosed with breast cancer found a significantly increased risk of CRC compared to population incidence rates [38]. This evidence concerns the gene BRCA1 and colorectal carcinoma.